Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Hajjar

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
European Journal of Heart Failure|December 15, 2015
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial designJozef Bartunek, Beth Davison, Warren Sherman, et al.
European Heart Journal|April 22, 2017
Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectivesWolfgang Poller, Stefanie Dimmeler, Stephane Heymans, et al.
Journal of the American College of Cardiology|April 9, 2016
Family-Based Approaches to Cardiovascular Health PromotionRajesh Vedanthan, Sameer Bansilal, Ana Victoria Soto, et al.
The Biochemical Journal|January 13, 2006
Ca2+-ATPases in non-failing and failing heart: evidence for a novel cardiac sarco/endoplasmic reticulum Ca2+-ATPase 2 isoform (SERCA2c)Saoussen Dally, Raymonde Bredoux, Elisabeth Corvazier, et al.
American Heart Journal|April 30, 2017
Rationale and Design of Family-Based Approach in a Minority Community Integrating Systems-Biology for Promotion of Health (FAMILIA)Sameer Bansilal, Rajesh Vedanthan, Jason C Kovacic, et al.
Journal of Molecular and Cellular Cardiology|November 25, 2017
HAX-1 regulates SERCA2a oxidation and degradationPhilip A Bidwell, Guan-Sheng Liu, Narayani Nagarajan, et al.
Stem Cell Reports|July 17, 2018
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Human Medium- and Large-Sized ArteriesKatherine C Michelis, Aya Nomura-Kitabayashi, Laura Lecce, et al.
The FEBS Journal|May 28, 2022
SUMOylation does not affect cardiac troponin I stability but alters indirectly the development of force in response to Ca<sup>2</sup>Bracy Fertig, Jiayue Ling, Edgar E Nollet, et al.
Circulation|January 30, 2020
Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial InfarctionYoav Hadas, Adam S Vincek, Elias Youssef, et al.
ESC Heart Failure|October 23, 2020
Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomesJozef Bartunek, Andre Terzic, Beth A Davison, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Heart Failure|December 15, 2015
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial designJozef Bartunek, Beth Davison, Warren Sherman, et al.
European Heart Journal|April 22, 2017
Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectivesWolfgang Poller, Stefanie Dimmeler, Stephane Heymans, et al.
Journal of the American College of Cardiology|April 9, 2016
Family-Based Approaches to Cardiovascular Health PromotionRajesh Vedanthan, Sameer Bansilal, Ana Victoria Soto, et al.
The Biochemical Journal|January 13, 2006
Ca2+-ATPases in non-failing and failing heart: evidence for a novel cardiac sarco/endoplasmic reticulum Ca2+-ATPase 2 isoform (SERCA2c)Saoussen Dally, Raymonde Bredoux, Elisabeth Corvazier, et al.
American Heart Journal|April 30, 2017
Rationale and Design of Family-Based Approach in a Minority Community Integrating Systems-Biology for Promotion of Health (FAMILIA)Sameer Bansilal, Rajesh Vedanthan, Jason C Kovacic, et al.
Journal of Molecular and Cellular Cardiology|November 25, 2017
HAX-1 regulates SERCA2a oxidation and degradationPhilip A Bidwell, Guan-Sheng Liu, Narayani Nagarajan, et al.
Stem Cell Reports|July 17, 2018
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Human Medium- and Large-Sized ArteriesKatherine C Michelis, Aya Nomura-Kitabayashi, Laura Lecce, et al.
The FEBS Journal|May 28, 2022
SUMOylation does not affect cardiac troponin I stability but alters indirectly the development of force in response to Ca<sup>2</sup>Bracy Fertig, Jiayue Ling, Edgar E Nollet, et al.
Circulation|January 30, 2020
Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial InfarctionYoav Hadas, Adam S Vincek, Elias Youssef, et al.
ESC Heart Failure|October 23, 2020
Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomesJozef Bartunek, Andre Terzic, Beth A Davison, et al.
Pageof 4